|
||||||||||||||||
HUM-MOLGEN -> Events -> Meetings and Conferences | ||||||||||||||||
Pharmacogenomics & SNPs in Drug Discovery & Development | ||||||||||||||||
January 07, 2002 | ||||||||||||||||
Strategic Research Institute, Newark Airport Marriot- Newark,NJ January 28-29 The Conference is organized into four sections: -SNPs & Disease: The Future of Medicine -New Drug Targets: SNP Identification in Disease-Causing Genes -Core Technologies for SNP Discovery & Analysis -Case Studies: Applications of Pharmacogenomic Technologies in Drug Development |
||||||||||||||||
Organized by: | Jon Liong | |||||||||||||||
Invited Speakers: | Arthur Holden,Ph.D./The SNP Consortium Thomas Casey,Ph.D./Cogene Biotech Ventures Joseph Hackett,M.D./FDa Klaus Lindpainter,Ph.D./F. Hoffman-La Roche AG Scott Stanley,Ph.D./ Genaissance Pharmaceuticals Catherine Burgess,Ph.D./Curagen John F. Morrison, Ph.D./Astrazeneca Emily Winn-Deen,Ph.D./Celera Genomics Philippe Jais, Ph.D.,M.D./Genset Dan O'Conner, M.D./University of Clifornia at San Diego Keith Jones,Ph.D./Affymetrix Michael S. Phillips,Ph.D./Orchid Biosciences Lynn Doucette-Stamm,Ph.D./Genome Therapeutics Stephen Toth,Ph.D./Pyrosequencing John Burczak,Ph.D./Amersham Biosciences James Leushner,Ph.D./Sequenom Lawrence Gelbert,Ph.D./Eli Lilly & Co. Colin Dykes, Ph.D./Variagenics Nicholas C. Dracopoli,Ph.D./Bristol-Myers Squibb |
|||||||||||||||
Deadline for Abstracts: | NA | |||||||||||||||
Registration: | Phone 888-666-8514/646-336-7030 8:30-5:30 EST M-F Fax 646-336-5891 www.srinstitute.com/cs189 |
|||||||||||||||
E-mail: | info@srinstitute.com | |||||||||||||||
Posted by: | Cheryl Kahan-Radhuber | |||||||||||||||
Host: | 12.3.58.15 | |||||||||||||||
|
||||||||||||||||
Generated by meetings and positions 5.0 by Kai Garlipp |